Study identifier:D5180C00034
ClinicalTrials.gov identifier:NCT05729711
EudraCT identifier:N/A
CTIS identifier:N/A
TEZSPIRE Subcutaneous Injection 210mg Specific use-results study (Long term) in patients with Bronchial asthma.
Bronchial asthma (only the patients with severe or intractable bronchial asthma which could not be controlled with the existing therapy)
N/A
No
-
All
400
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|